Q1 Sales in the UK.
$258,993 in 2016
$286,892 in 2015
That is on page 17 of the Q1 2016 financial statement.
How do you explain that decrease?
A Trial version cost $5, the 720 hour version costs about $30. Sales in the UK should have been MUCH higher in 2016 if people who used the trial version came back as loyal customers.
Have you used the ActiPatch? I have. It was hard to tell if it had any benefit at all. One thing is for sure: aspirin, tylenol, Aleve, and ice all worked faster and all reduced pain more than the ActiPatch.
The clinicals show that it has some benefit when used over time. But is THAT enough to generate significant OTC sales? In the UK, it appears not.